abt-20220930
000000180012-312022Q3falseP12M00000018002022-01-012022-09-300000001800exch:XCHI2022-01-012022-09-300000001800exch:XNYS2022-01-012022-09-3000000018002022-09-30xbrli:shares00000018002022-07-012022-09-30iso4217:USD00000018002021-07-012021-09-3000000018002021-01-012021-09-30iso4217:USDxbrli:shares00000018002021-12-310000001800us-gaap:CommonStockMember2022-06-300000001800us-gaap:CommonStockMember2021-06-300000001800us-gaap:CommonStockMember2022-07-012022-09-300000001800us-gaap:CommonStockMember2021-07-012021-09-300000001800us-gaap:CommonStockMember2022-09-300000001800us-gaap:CommonStockMember2021-09-300000001800us-gaap:TreasuryStockCommonMember2022-06-300000001800us-gaap:TreasuryStockCommonMember2021-06-300000001800us-gaap:TreasuryStockCommonMember2022-07-012022-09-300000001800us-gaap:TreasuryStockCommonMember2021-07-012021-09-300000001800us-gaap:TreasuryStockCommonMember2022-09-300000001800us-gaap:TreasuryStockCommonMember2021-09-300000001800us-gaap:RetainedEarningsMember2022-06-300000001800us-gaap:RetainedEarningsMember2021-06-300000001800us-gaap:RetainedEarningsMember2022-07-012022-09-300000001800us-gaap:RetainedEarningsMember2021-07-012021-09-300000001800us-gaap:RetainedEarningsMember2022-09-300000001800us-gaap:RetainedEarningsMember2021-09-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300000001800us-gaap:NoncontrollingInterestMember2022-06-300000001800us-gaap:NoncontrollingInterestMember2021-06-300000001800us-gaap:NoncontrollingInterestMember2022-07-012022-09-300000001800us-gaap:NoncontrollingInterestMember2021-07-012021-09-300000001800us-gaap:NoncontrollingInterestMember2022-09-300000001800us-gaap:NoncontrollingInterestMember2021-09-300000001800us-gaap:CommonStockMember2021-12-310000001800us-gaap:CommonStockMember2020-12-310000001800us-gaap:CommonStockMember2022-01-012022-09-300000001800us-gaap:CommonStockMember2021-01-012021-09-300000001800us-gaap:TreasuryStockCommonMember2021-12-310000001800us-gaap:TreasuryStockCommonMember2020-12-310000001800us-gaap:TreasuryStockCommonMember2022-01-012022-09-300000001800us-gaap:TreasuryStockCommonMember2021-01-012021-09-300000001800us-gaap:RetainedEarningsMember2021-12-310000001800us-gaap:RetainedEarningsMember2020-12-310000001800us-gaap:RetainedEarningsMember2022-01-012022-09-300000001800us-gaap:RetainedEarningsMember2021-01-012021-09-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300000001800us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300000001800us-gaap:NoncontrollingInterestMember2021-12-310000001800us-gaap:NoncontrollingInterestMember2020-12-310000001800us-gaap:NoncontrollingInterestMember2022-01-012022-09-300000001800us-gaap:NoncontrollingInterestMember2021-01-012021-09-3000000018002020-12-3100000018002021-09-30abt:segment0000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2022-07-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2021-07-012021-09-300000001800abt:OtherEmergingMarketsMembercountry:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-07-012022-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-07-012022-09-300000001800abt:OtherEmergingMarketsMembercountry:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-07-012021-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-07-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-07-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-07-012021-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2022-07-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2022-07-012022-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2021-07-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2021-07-012021-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800abt:CoreLaboratoryMembercountry:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800abt:CoreLaboratoryMembercountry:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMemberus-gaap:NonUsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2022-07-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMemberus-gaap:NonUsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2021-07-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800country:USabt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800country:USabt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-07-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-07-012021-09-300000001800abt:RhythmManagementMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:RhythmManagementMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2022-07-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2021-07-012021-09-300000001800abt:HeartFailureMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:HeartFailureMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2022-07-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2021-07-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:StructuralHeartMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2022-07-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:StructuralHeartMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2021-07-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2022-07-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2021-07-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiabetesCareMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2022-07-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiabetesCareMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2021-07-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-07-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-07-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800country:USus-gaap:CorporateNonSegmentMember2022-07-012022-09-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2022-07-012022-09-300000001800us-gaap:CorporateNonSegmentMember2022-07-012022-09-300000001800country:USus-gaap:CorporateNonSegmentMember2021-07-012021-09-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2021-07-012021-09-300000001800us-gaap:CorporateNonSegmentMember2021-07-012021-09-300000001800country:US2022-07-012022-09-300000001800us-gaap:NonUsMember2022-07-012022-09-300000001800country:US2021-07-012021-09-300000001800us-gaap:NonUsMember2021-07-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2022-01-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMemberabt:KeyEmergingMarketsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberabt:KeyEmergingMarketsMember2021-01-012021-09-300000001800abt:OtherEmergingMarketsMembercountry:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-01-012022-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-01-012022-09-300000001800abt:OtherEmergingMarketsMembercountry:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-01-012021-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:OtherEmergingMarketsMemberus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-01-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2022-01-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:EstablishedPharmaceuticalProductsMember2021-01-012021-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:PediatricNutritionalsMemberabt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2022-01-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2022-01-012022-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2021-01-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberabt:AdultNutritionalsMember2021-01-012021-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:NutritionalProductsMembercountry:USus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:NutritionalProductsMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800abt:CoreLaboratoryMembercountry:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800abt:CoreLaboratoryMembercountry:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:CoreLaboratoryMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMemberus-gaap:NonUsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2022-01-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMemberus-gaap:NonUsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberabt:MolecularMember2021-01-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:PointOfCareMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800country:USabt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800country:USabt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:RapidDiagnosticsMemberus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2022-01-012022-09-300000001800country:USus-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800us-gaap:OperatingSegmentsMemberabt:DiagnosticProductsMember2021-01-012021-09-300000001800abt:RhythmManagementMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:RhythmManagementMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:RhythmManagementMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2022-01-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:ElectrophysiologyMember2021-01-012021-09-300000001800abt:HeartFailureMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:HeartFailureMembercountry:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:HeartFailureMemberabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2022-01-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:VascularMember2021-01-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:StructuralHeartMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2022-01-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:StructuralHeartMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:StructuralHeartMember2021-01-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2022-01-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:NeuromodulationMember2021-01-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiabetesCareMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2022-01-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMemberabt:DiabetesCareMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberabt:DiabetesCareMember2021-01-012021-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2022-01-012022-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800country:USabt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMemberus-gaap:NonUsMember2021-01-012021-09-300000001800abt:MedicalDevicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800country:USus-gaap:CorporateNonSegmentMember2022-01-012022-09-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2022-01-012022-09-300000001800us-gaap:CorporateNonSegmentMember2022-01-012022-09-300000001800country:USus-gaap:CorporateNonSegmentMember2021-01-012021-09-300000001800us-gaap:CorporateNonSegmentMemberus-gaap:NonUsMember2021-01-012021-09-300000001800us-gaap:CorporateNonSegmentMember2021-01-012021-09-300000001800country:US2022-01-012022-09-300000001800us-gaap:NonUsMember2022-01-012022-09-300000001800country:US2021-01-012021-09-300000001800us-gaap:NonUsMember2021-01-012021-09-300000001800abt:DiagnosticProductsMember2022-09-300000001800abt:MedicalDevicesMember2022-09-3000000018002022-10-012022-01-012022-09-30xbrli:pure00000018002022-10-012022-09-3000000018002024-10-012022-01-012022-09-3000000018002024-10-012022-09-300000001800us-gaap:PensionPlansDefinedBenefitMember2022-01-012022-09-300000001800us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-09-300000001800us-gaap:EquitySecuritiesMember2022-09-300000001800us-gaap:EquitySecuritiesMember2021-12-310000001800us-gaap:OtherInvestmentsMember2022-09-300000001800us-gaap:OtherInvestmentsMember2021-12-310000001800abt:StJudeMedicalIncMemberus-gaap:EquitySecuritiesMember2022-09-300000001800abt:WalkVascularLLCMember2021-09-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-06-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-06-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-07-012022-09-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-07-012021-09-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-012022-09-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-07-012021-09-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-012021-09-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-09-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-09-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-09-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000001800us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310000001800us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300000001800us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-09-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-09-300000001800us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-09-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-300000001800us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-09-300000001800abt:EstablishedPharmaceuticalProductsMember2022-09-300000001800abt:NutritionalProductsMember2022-09-300000001800abt:MedicalDevicesMember2022-07-012022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMember2021-04-012021-06-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:FixedAssetWriteDownsMember2021-04-012021-06-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:InventoryRelatedChargesMember2021-04-012021-06-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:OtherExitCostsMember2021-04-012021-06-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMember2021-07-012021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:OtherExitCostsMember2021-07-012021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:InventoryRelatedChargesMember2021-01-012021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:FixedAssetWriteDownsMember2021-01-012021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:OtherExitCostsMember2021-01-012021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMember2021-01-012021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:InventoryRelatedChargesMember2021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:FixedAssetWriteDownsMember2021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:OtherExitCostsMember2021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMember2021-12-310000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:InventoryRelatedChargesMember2022-01-012022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:FixedAssetWriteDownsMember2022-01-012022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:OtherExitCostsMember2022-01-012022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMember2022-01-012022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:InventoryRelatedChargesMember2022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:FixedAssetWriteDownsMember2022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMemberabt:OtherExitCostsMember2022-09-300000001800abt:COVID19TestManufacturingNetworkRestructuringPlanMember2022-09-300000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2022-01-012022-09-300000001800abt:CostOfGoodsAndServicesSoldMemberabt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2022-01-012022-09-300000001800us-gaap:ResearchAndDevelopmentExpenseMemberabt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2022-01-012022-09-300000001800us-gaap:SellingGeneralAndAdministrativeExpensesMemberabt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2022-01-012022-09-300000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2021-01-012021-12-310000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2021-12-310000001800abt:RestructuringPlan2021StreamlineOfOperationsAndImproveEfficienciesMember2022-09-300000001800us-gaap:EmployeeStockOptionMember2022-01-012022-09-300000001800abt:RestrictedStockAwardsMember2022-01-012022-09-300000001800us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300000001800us-gaap:EmployeeStockOptionMember2022-09-300000001800abt:A255LongTermNotesDue2022Member2022-03-152022-03-150000001800abt:A255LongTermNotesDue2022Member2022-03-150000001800us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000001800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-09-300000001800us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-12-310000001800abt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000001800abt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-12-310000001800abt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800abt:YenDenominatedLongTermDebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800us-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:FairValueHedgingMemberabt:DeferredIncomeTaxesAndOtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800us-gaap:FairValueHedgingMemberabt:DeferredIncomeTaxesAndOtherAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:FairValueHedgingMemberabt:PostemploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800us-gaap:FairValueHedgingMemberabt:PostemploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800us-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2022-09-300000001800abt:PrepaidExpensesAndOtherReceivablesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-12-310000001800us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2022-09-300000001800us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2021-12-310000001800us-gaap:LongTermDebtMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300000001800us-gaap:LongTermDebtMemberus-gaap:DebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000001800us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2022-07-012022-09-300000001800us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2021-07-012021-09-300000001800us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2022-01-012022-09-300000001800us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2021-01-012021-09-300000001800us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300000001800us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-012021-09-300000001800us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000001800us-gaap:DebtMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000001800us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300000001800us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-012021-09-300000001800us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000001800us-gaap:FairValueHedgingMemberus-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300000001800us-gaap:ForeignExchangeForwardMember2022-07-012022-09-300000001800us-gaap:ForeignExchangeForwardMember2021-07-012021-09-300000001800us-gaap:ForeignExchangeForwardMember2022-01-012022-09-300000001800us-gaap:ForeignExchangeForwardMember2021-01-012021-09-300000001800us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2022-09-300000001800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2022-09-300000001800us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2021-12-310000001800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2021-12-310000001800us-gaap:OtherAggregatedInvestmentsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000001800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:OtherAggregatedInvestmentsMember2022-09-300000001800us-gaap:OtherAggregatedInvestmentsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000001800us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:OtherAggregatedInvestmentsMember2021-12-310000001800us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300000001800us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300000001800us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000001800us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000001800us-gaap:FairValueMeasurementsRecurringMember2022-09-300000001800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-09-300000001800us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-09-300000001800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300000001800us-gaap:FairValueMeasurementsRecurringMember2021-12-310000001800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000001800us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000001800us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000001800abt:LegalProceedingsAndEnvironmentalExposuresMembersrt:MinimumMember2022-09-300000001800abt:LegalProceedingsAndEnvironmentalExposuresMembersrt:MaximumMember2022-09-300000001800abt:LegalProceedingsAndEnvironmentalExposuresMember2022-09-300000001800us-gaap:PensionPlansDefinedBenefitMember2022-07-012022-09-300000001800us-gaap:PensionPlansDefinedBenefitMember2021-07-012021-09-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-07-012022-09-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-07-012021-09-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2022-01-012022-09-300000001800us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-09-300000001800srt:MinimumMember2022-09-300000001800srt:MaximumMember2022-09-300000001800us-gaap:OperatingSegmentsMember2022-07-012022-09-300000001800us-gaap:OperatingSegmentsMember2021-07-012021-09-300000001800us-gaap:OperatingSegmentsMember2022-01-012022-09-300000001800us-gaap:OperatingSegmentsMember2021-01-012021-09-300000001800us-gaap:MaterialReconcilingItemsMember2022-07-012022-09-300000001800us-gaap:MaterialReconcilingItemsMember2021-07-012021-09-300000001800us-gaap:MaterialReconcilingItemsMember2022-01-012022-09-300000001800us-gaap:MaterialReconcilingItemsMember2021-01-012021-09-300000001800abt:NutritionalProductsMember2022-07-012022-09-300000001800abt:NutritionalProductsMember2022-01-012022-09-300000001800abt:MedicalDevicesMember2022-01-012022-09-30
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to
Commission File No. 1-2189
ABBOTT LABORATORIES
An Illinois Corporation
I.R.S. Employer Identification No.
36-0698440
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
Telephone: (224) 667-6100
Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Shares, Without Par ValueABT
New York Stock Exchange
Chicago Stock Exchange, Inc.
Indicate by check mark whether the registrant: (l) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of l934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer x
Accelerated Filer o
Non-Accelerated Filer o
Smaller reporting company o
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
As of September 30, 2022, Abbott Laboratories had 1,743,573,777 common shares without par value outstanding.


Table of Contents
Abbott Laboratories
Table of Contents
Page
2

Table of Contents


Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Earnings
(Unaudited)
(dollars in millions except per share data; shares in thousands)
Three Months Ended Nine Months Ended
September 30September 30
2022202120222021
Net sales$10,410 $10,928 $33,562 $31,607 
Cost of products sold, excluding amortization of intangible assets4,629 4,423 14,549 13,771 
Amortization of intangible assets498 520 1,517 1,533 
Research and development782 672 2,163 1,980 
Selling, general and administrative2,731 2,767 8,275 8,276 
Total operating cost and expenses8,640 8,382 26,504 25,560 
Operating earnings1,770 2,546 7,058 6,047 
Interest expense141 133 404 402 
Interest (income)(55)(10)(95)(32)
Net foreign exchange (gain) loss19 4 16 7 
Other (income) expense, net(93)(74)(253)(214)
Earnings before taxes1,758 2,493 6,986 5,884 
Taxes on earnings323 393 1,086 802 
Net Earnings$1,435 $2,100 $5,900 $5,082 
Basic Earnings Per Common Share$0.82 $1.18 $3.35 $2.85 
Diluted Earnings Per Common Share$0.81 $1.17 $3.32 $2.83 
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share1,752,968 1,774,516 1,756,209 1,776,870 
Dilutive Common Stock Options10,685 14,483 11,638 14,407 
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options1,763,653 1,788,999 1,767,847 1,791,277 
Outstanding Common Stock Options Having No Dilutive Effect5,445 2,740 2,655 2,694 
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
3

Table of Contents
Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Comprehensive Income
(Unaudited)
(dollars in millions)
Three Months EndedNine Months Ended
September 30September 30
2022202120222021
Net Earnings$1,435 $2,100 $5,900 $5,082 
Foreign currency translation gain (loss) adjustments(1,008)(391)(1,429)(762)
Net actuarial gains (losses) and amortization of net actuarial losses and prior service costs and credits, net of taxes of $11 and $36 in 2022 and $18 and $54 in 2021
56 78 172 211 
Net gains (losses) for derivative instruments designated as cash flow hedges and other, net of taxes of $50 and $96 in 2022 and $50 and $98 in 2021
213 139 186 257 
Other comprehensive income (loss)(739)(174)(1,071)(294)
Comprehensive Income$696 $1,926 $4,829 $4,788 
September 30,
2022
December 31,
2021
Supplemental Accumulated Other Comprehensive Income (Loss) Information, net of tax:
Cumulative foreign currency translation (loss) adjustments$(7,268)$(5,839)
Net actuarial (losses) and prior service (costs) and credits(2,498)(2,670)
Cumulative gains (losses) on derivative instruments designated as cash flow hedges and other321 135 
Accumulated other comprehensive income (loss)$(9,445)$(8,374)
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
4

Table of Contents
Abbott Laboratories and Subsidiaries
Condensed Consolidated Balance Sheet
(Unaudited)
(dollars in millions)
September 30,
2022
December 31,
2021
Assets
Current Assets:
Cash and cash equivalents$9,594 $9,799 
Short-term investments313 450 
Trade receivables, less allowances of $520 in 2022 and $519 in 2021
6,408 6,487 
Inventories:
Finished products3,407 3,081 
Work in process726 694 
Materials1,601 1,382 
Total inventories5,734 5,157 
Prepaid expenses and other receivables2,796 2,346 
Total Current Assets24,845 24,239 
Investments764 816 
Property and equipment, at cost19,306 19,364 
Less: accumulated depreciation and amortization10,617 10,405 
Net property and equipment8,689 8,959 
Intangible assets, net of amortization10,850 12,739 
Goodwill22,284 23,231 
Deferred income taxes and other assets5,369 5,212 
$72,801 $75,196 
Liabilities and Shareholders’ Investment
Current Liabilities:
Trade accounts payable$4,133 $4,408 
Salaries, wages and commissions1,426 1,625 
Other accrued liabilities5,475 5,181 
Dividends payable820 831 
Income taxes payable394 306 
Current portion of long-term debt1,117 754 
Total Current Liabilities13,365 13,105 
Long-term debt15,297 17,296 
Post-employment obligations, deferred income taxes and other long-term liabilities8,255 8,771 
Commitments and Contingencies
Shareholders’ Investment:
Preferred shares, one dollar par value Authorized — 1,000,000 shares, none issued
  
Common shares, without par value Authorized — 2,400,000,000 shares
Issued at stated capital amount — Shares: 2022: 1,985,919,440; 2021: 1,985,273,421
24,560 24,470 
Common shares held in treasury, at cost — Shares: 2022: 242,345,663; 2021: 221,191,228
(14,555)(11,822)
Earnings employed in the business35,115 31,528 
Accumulated other comprehensive income (loss)(9,445)(8,374)
Total Abbott Shareholders’ Investment35,675 35,802 
Noncontrolling Interests in Subsidiaries209 222 
Total Shareholders’ Investment35,884 36,024 
$72,801 $75,196 
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
5

Table of Contents
Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Shareholders’ Investment
(Unaudited)
(in millions except shares and per share data)
Three Months Ended September 30
20222021
Common Shares:
Balance at June 30
Shares: 2022: 1,985,676,735; 2021: 1,982,553,488
$24,429 $24,153 
Issued under incentive stock programs  
Shares: 2022: 242,705; 2021: 550,366
12 26 
Share-based compensation123 113 
Issuance of restricted stock awards(4)(7)
Balance at September 30  
Shares: 2022: 1,985,919,440; 2021: 1,983,103,854
$24,560 $24,285 
Common Shares Held in Treasury:
Balance at June 30
Shares: 2022: 234,456,992; 2021: 209,736,139
$(13,720)$(10,340)
Issued under incentive stock programs  
Shares: 2022: 528,436; 2021: 545,860
31 26 
Purchased  
Shares: 2022: 8,417,107; 2021: 5,626,606
(866)(685)
Balance at September 30  
Shares: 2022: 242,345,663; 2021: 214,816,885
$(14,555)$(10,999)
Earnings Employed in the Business:
Balance at June 30$34,487 $29,053 
Net earnings1,435 2,100 
Cash dividends declared on common shares (per share — 2022: $0.47; 2021: $0.45)
(822)(799)
Effect of common and treasury share transactions15 22 
Balance at September 30$35,115 $30,376 
Accumulated Other Comprehensive Income (Loss):
Balance at June 30$(8,706)$(9,066)
Other comprehensive income (loss)(739)(174)
Balance at September 30$(9,445)$(9,240)
Noncontrolling Interests in Subsidiaries:
Balance at June 30$226 $229 
Noncontrolling Interests’ share of income, business combinations, net of distributions and share repurchases(17)(13)
Balance at September 30$209 $216 
The accompanying notes to condensed consolidated financial statements are an integral part of this statement.
6

Table of Contents
Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Shareholders’ Investment
(Unaudited)
(in millions except shares and per share data)
Nine Months Ended September 30
20222021
Common Shares:
Balance at January 1
Shares: 2022: 1,985,273,421; 2021: 1,981,156,896
$24,470 $24,145 
Issued under incentive stock programs
Shares: 2022: 646,019; 2021: 1,946,958
36 91 
Share-based compensation572 536 
Issuance of restricted stock awards(518)(487)
Balance at September 30
Shares: 2022: 1,985,919,440; 2021: 1,983,103,854
$24,560 $24,285 
Common Shares Held in Treasury:
Balance at January 1
Shares: 2022: 221,191,228; 2021: 209,926,622
$(11,822)$(10,042)
Issued under incentive stock programs
Shares: 2022: 4,808,575; 2021: 5,524,291
261 265 
Purchased
Shares: 2022: 25,963,010; 2021: 10,414,554
(2,994)(1,222)
Balance at September 30
Shares: 2022: 242,345,663; 2021: 214,816,885
$(14,555)$(10,999)
Earnings Employed in the Business:
Balance at January 1$31,528 $27,627 
Net earnings5,900 5,082 
Cash dividends declared on common shares (per share — 2022: $1.41; 2021: $1.35)
(2,475)(2,403)
Effect of common and treasury share transactions162 70 
Balance at September 30$35,115 $30,376 
Accumulated Other Comprehensive Income (Loss):
Balance at January 1$(8,374)$(8,946)
Other comprehensive income (loss)(1,071)(294)
Balance at September 30$(9,445)$(9,240)
Noncontrolling Interests in Subsidiaries:
Balance at January 1$222 $219 
Noncontrolling Interests’ share of income, business combinations, net of distributions and share repurchases(13)(3)
Balance at September 30$209 $216 
The accompanying notes to condensed consolidated financial statements are an integral part of this statement.
7

Table of Contents
Abbott Laboratories and Subsidiaries
Condensed Consolidated Statement of Cash Flows
(Unaudited)
(dollars in millions)
Nine Months Ended September 30
20222021
Cash Flow From (Used in) Operating Activities:
Net earnings$5,900 $5,082 
Adjustments to reconcile net earnings to net cash from operating activities —
Depreciation943 1,122 
Amortization of intangible assets1,517 1,533 
Share-based compensation570 534 
Trade receivables(409)(194)
Inventories(1,224)(471)
Other, net(42)(140)
Net Cash From Operating Activities7,255 7,466 
Cash Flow From (Used in) Investing Activities:
Acquisitions of property and equipment(1,167)(1,271)
Acquisitions of businesses and technologies, net of cash acquired (187)
Proceeds from business dispositions48 134 
Sales (purchases) of other investment securities, net(3)(27)
Other14 14 
Net Cash From (Used in) Investing Activities(1,108)(1,337)
Cash Flow From (Used in) Financing Activities:
Net borrowings (repayments) of short-term debt and other37 (7)
Proceeds from issuance of long-term debt7  
Repayments of long-term debt(753)(45)
Purchases of common shares(3,110)(1,325)
Proceeds from stock options exercised126 173 
Dividends paid(2,486)(2,404)
Net Cash From (Used in) Financing Activities(6,179)(3,608)
Effect of exchange rate changes on cash and cash equivalents(173)(57)
Net Increase (Decrease) in Cash and Cash Equivalents(205)2,464 
Cash and Cash Equivalents, Beginning of Year9,799 6,838 
Cash and Cash Equivalents, End of Period$9,594 $9,302 
The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.
8

Table of Contents
Abbott Laboratories and Subsidiaries
Notes to the Condensed Consolidated Financial Statements
September 30, 2022
(Unaudited)

Note 1 — Basis of Presentation

The accompanying unaudited, condensed consolidated financial statements have been prepared pursuant to rules and regulations of the Securities and Exchange Commission and, therefore, do not include all information and footnote disclosures normally included in audited financial statements. However, in the opinion of management, all adjustments (which include only normal adjustments) necessary to present fairly the results of operations, financial position and cash flows have been made. It is suggested that these statements be read in conjunction with the financial statements included in Abbott’s Annual Report on Form 10-K for the year ended December 31, 2021. The condensed consolidated financial statements include the accounts of the parent company and subsidiaries, after elimination of intercompany transactions.

Note 2 — Revenue

Abbott’s revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements. Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The following tables provide detail by sales category:

Three Months Ended September 30, 2022Three Months Ended September 30, 2021
(in millions)U.S.Int’lTotalU.S.Int’lTotal
Established Pharmaceutical Products —
Key Emerging Markets$ $993 $993 $ $936 $936 
Other 333 333  329 329 
Total 1,326 1,326  1,265 1,265 
Nutritionals —    
Pediatric Nutritionals357 470 827 586 514 1,100 
Adult Nutritionals329 639 968 333 675 1,008 
Total686 1,109 1,795 919 1,189 2,108 
Diagnostics —     
Core Laboratory281 938 1,219 291 1,001 1,292 
Molecular65 118 183 162 183 345 
Point of Care92 35 127 100 35 135 
Rapid Diagnostics1,303 839 2,142 1,394 746 2,140 
Total1,741 1,930 3,671 1,947 1,965 3,912 
Medical Devices —    
Rhythm Management263 270 533 266 305 571 
Electrophysiology225 244 469 192 293 485 
Heart Failure177 51 228 170 59 229 
Vascular213 393 606 219 425 644 
Structural Heart207 213 420 177 215 392 
Neuromodulation156 36 192 149 41 190 
Diabetes Care 423 744 1,167 323 798 1,121 
Total1,664 1,951 3,615 1,496 2,136 3,632 
Other3  3 6 5 11 
Total$4,094 $6,316 $10,410 $4,368 $6,560 $10,928 
9

Table of Contents
Abbott Laboratories and Subsidiaries
Notes to the Condensed Consolidated Financial Statements
September 30, 2022
(Unaudited)
Note 2 — Revenue (Continued)
Nine Months Ended September 30, 2022Nine Months Ended September 30, 2021
(in millions)U.S.Int’lTotal U.S.Int’lTotal
Established Pharmaceutical Products —
Key Emerging Markets$ $2,826 $2,826 $ $2,672 $2,672 
Other 870 870  843 843 
Total 3,696 3,696  3,515 3,515 
Nutritionals —    
Pediatric Nutritionals1,108 1,491 2,599 1,622 1,637 3,259 
Adult Nutritionals1,016 2,027 3,043 1,006 1,987 2,993 
Total2,124 3,518 5,642 2,628 3,624 6,252 
Diagnostics —
Core Laboratory836 2,788 3,624 845 2,935 3,780 
Molecular308 507 815 431 651 1,082 
Point of Care284 110 394 289 112 401 
Rapid Diagnostics5,523 2,923 8,446 3,178 2,732 5,910 
Total